| Year |
Citation |
Score |
| 2020 |
Sze KM, Ho DW, Chiu YT, Tsui YM, Chan LK, Lee JM, Chok KS, Chan AC, Tang CN, Tang VW, Lo IL, Yau DT, Cheung TT, Ng IO. HBV-TERT Promoter Integration Harnesses Host ELF4 Resulting in TERT Gene Transcription in Hepatocellular Carcinoma. Hepatology (Baltimore, Md.). PMID 32170761 DOI: 10.1002/hep.31231 |
0.412 |
|
| 2019 |
Fako V, Martin SP, Pomyen Y, Budhu A, Chaisaingmongkol J, Franck S, Lee JM, Ng IO, Cheung TT, Wei X, Liu N, Ji J, Zhao L, Liu Z, Jia HL, et al. Gene signature predictive of hepatocellular carcinoma patient response to transarterial chemoembolization. International Journal of Biological Sciences. 15: 2654-2663. PMID 31754337 DOI: 10.7150/Ijbs.39534 |
0.362 |
|
| 2019 |
Ng KK, Cheung TT, Pang HH, Wong TC, Dai JW, Ma KW, She WH, Kotewall CN, Lo CM. A simplified prediction model for early intrahepatic recurrence after hepatectomy for patients with unilobar hepatocellular carcinoma without macroscopic vascular invasion: An implication for adjuvant therapy and postoperative surveillance. Surgical Oncology. 30: 6-12. PMID 31500787 DOI: 10.1016/j.suronc.2019.05.017 |
0.449 |
|
| 2019 |
Berardi G, Morise Z, Sposito C, Igarashi K, Panetta V, Simonelli I, Kim S, Goh BKP, Kubo S, Tanaka S, Takeda Y, Ettorre GM, Wilson GC, Cimino M, Chan CY, ... ... Cheung TT, et al. Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in child-pugh b cirrhosis. Journal of Hepatology. PMID 31499131 DOI: 10.1016/j.jhep.2019.08.032 |
0.439 |
|
| 2019 |
Cheung TT. Management of hepatocellular carcinoma: from bench to bedside and beyond. Translational Gastroenterology and Hepatology. 4: 54. PMID 31463413 DOI: 10.21037/tgh.2019.07.01 |
0.378 |
|
| 2019 |
Chan MY, She WH, Dai WC, Tsang SHY, Chok KSH, Chan ACY, Fung J, Lo CM, Cheung TT. Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong. Translational Gastroenterology and Hepatology. 4: 52. PMID 31463411 DOI: 10.21037/tgh.2019.06.07 |
0.329 |
|
| 2019 |
Huang FY, Wong DK, Tsui VW, Seto WK, Mak LY, Cheung TT, Lai KK, Yuen MF. Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma. Bmc Cancer. 19: 789. PMID 31395065 DOI: 10.1186/S12885-019-6002-9 |
0.471 |
|
| 2019 |
Ka-Ho Wong D, Yan Cheng SC, Lung-Yi Mak L, Wai-Pan To E, Cheuk-Lam Lo R, Cheung TT, Seto WK, Fung J, Man K, Lai CL, Yuen MF. Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 31252193 DOI: 10.1016/J.Cgh.2019.06.029 |
0.372 |
|
| 2019 |
Ho DW, Tsui YM, Sze KM, Chan LK, Cheung TT, Lee E, Sham PC, Tsui SK, Lee TK, Ng IO. Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancer. Cancer Letters. PMID 31195060 DOI: 10.1016/J.Canlet.2019.06.002 |
0.436 |
|
| 2019 |
Fung SW, Fung-Yi Cheung P, Yip CW, Wing-Chi Ng L, Cheung TT, Ching-Ning Chong C, Lee C, Bo-San Lai P, Wing-Hung Chan A, Sai-Wah Tsao G, Wong CH, Chan SL, Lo KW, Cheung ST. The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemo-resistance, EMT and cancer stemness in hepatocellular carcinoma. Cancer Letters. PMID 31100412 DOI: 10.1016/j.canlet.2019.05.010 |
0.543 |
|
| 2019 |
Ma KW, She WH, Chan ACY, Cheung TT, Fung JYY, Dai WC, Lo CM, Chok KSH. Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population. World Journal of Gastrointestinal Oncology. 11: 322-334. PMID 31040897 DOI: 10.4251/wjgo.v11.i4.322 |
0.413 |
|
| 2019 |
Wong TC, Chiang CL, Lee AS, Lee VH, Yeung CS, Ho CH, Cheung TT, Ng KK, Chok SH, Chan AC, Dai WC, Wong FC, Luk MY, Leung TW, Lo CM. Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis. Surgical Oncology. 28: 228-235. PMID 30851906 DOI: 10.1016/j.suronc.2019.01.006 |
0.407 |
|
| 2019 |
Wong TCL, Ng KKC, Fung JYY, Chan AAC, Cheung TT, Chok KSH, Dai JWC, Lo CM. Long-Term Survival Outcome Between Living Donor and Deceased Donor Liver Transplant for Hepatocellular Carcinoma: Intention-to-Treat and Propensity Score Matching Analyses. Annals of Surgical Oncology. PMID 30737669 DOI: 10.1245/s10434-019-07206-0 |
0.322 |
|
| 2019 |
Ma KW, She WH, Cheung TT, Chan ACY, Dai WC, Fung JYY, Lo CM, Chok KSH. Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy. Surgery Today. PMID 30637484 DOI: 10.1007/s00595-019-1764-x |
0.433 |
|
| 2018 |
Lee D, Xu IM, Chiu DK, Leibold J, Tse AP, Bao MH, Yuen VW, Chan CY, Lai RK, Chin DW, Chan DF, Cheung TT, Chok SH, Wong CM, Lowe SW, et al. Induction of Oxidative Stress via Inhibition of Thioredoxin Reductase 1 is an Effective Therapeutic Approach for Hepatocellular Carcinoma. Hepatology (Baltimore, Md.). PMID 30561826 DOI: 10.1002/hep.30467 |
0.491 |
|
| 2018 |
Kotewall CN, Cheung TT. Optimizing hepatectomy for hepatocellular carcinoma in Asia-patient selection and special considerations. Translational Gastroenterology and Hepatology. 3: 75. PMID 30505962 DOI: 10.21037/tgh.2018.09.09 |
0.476 |
|
| 2018 |
Raoul JL, Forner A, Bolondi L, Cheung TT, Kloeckner R, de Baere T. Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence. Cancer Treatment Reviews. 72: 28-36. PMID 30447470 DOI: 10.1016/j.ctrv.2018.11.002 |
0.492 |
|
| 2018 |
Ng KKC, Cheung TT, Wong TCL, Fung JYY, Dai JWC, Ma KW, She WH, Lo CM. Long-term survival comparison between primary transplant and upfront curative treatment with salvage transplant for early stage hepatocellular carcinoma. Asian Journal of Surgery. PMID 30262437 DOI: 10.1016/j.asjsur.2018.08.008 |
0.393 |
|
| 2018 |
Lo KS, Chan MY, Ma KW, Tsang SH, Cheung TT, Lo CM. Left hepatectomy in a patient with a Fontan circulation. Translational Gastroenterology and Hepatology. 3: 51. PMID 30225385 DOI: 10.21037/tgh.2018.07.10 |
0.305 |
|
| 2018 |
Wu CX, Wang XQ, Chok SH, Man K, Tsang SHY, Chan ACY, Ma KW, Xia W, Cheung TT. Blocking CDK1/PDK1/β-Catenin signaling by CDK1 inhibitor RO3306 increased the efficacy of sorafenib treatment by targeting cancer stem cells in a preclinical model of hepatocellular carcinoma. Theranostics. 8: 3737-3750. PMID 30083256 DOI: 10.7150/thno.25487 |
0.409 |
|
| 2018 |
Cheung TT, Ma KW, She WH, Dai WC, Tsang SHY, Chan ACY, Chok KSH, Lo CM. Pure laparoscopic hepatectomy with augmented reality-assisted indocyanine green fluorescence versus open hepatectomy for hepatocellular carcinoma with liver cirrhosis: A propensity analysis at a single center. Asian Journal of Endoscopic Surgery. PMID 29747235 DOI: 10.1111/ases.12492 |
0.445 |
|
| 2018 |
Ma KW, Chan ACY, She BWH, Chok KSH, Cheung TT, Dai JWC, Fung JYY, Lo CM. Changing Paradigm in the Surgical Management of Hepatocellular Carcinoma With Salvage Transplantation. Transplantation Proceedings. 50: 1087-1093. PMID 29731072 DOI: 10.1016/j.transproceed.2018.01.025 |
0.44 |
|
| 2018 |
Cheung TT, Kwok PC, Chan S, Cheung CC, Lee AS, Lee V, Cheng HC, Chia NH, Chong CCN, Lai TW, Law ALY, Luk MY, Tong CC, Yau TCC. Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma. Liver Cancer. 7: 40-54. PMID 29662832 DOI: 10.1159/000485984 |
0.509 |
|
| 2018 |
Cheung TT, Han HS, She WH, Chen KH, Chow PKH, Yoong BK, Lee KF, Kubo S, Tang CN, Wakabayashi G. The Asia Pacific Consensus Statement on Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Report from the 7th Asia-Pacific Primary Liver Cancer Expert Meeting Held in Hong Kong. Liver Cancer. 7: 28-39. PMID 29662831 DOI: 10.1159/000481834 |
0.44 |
|
| 2018 |
Ma KW, Chok KSH, She BWH, Chan ACY, Cheung TT, Dai JWC, Fung JYY, Lo CM. Defining Optimal Surgical Treatment for Recurrent Hepatocellular Carcinoma. -A Propensity Score Matched Analysis. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 29451360 DOI: 10.1002/lt.25033 |
0.351 |
|
| 2018 |
Ma KW, Chok KSH, She WH, Cheung TT, Chan ACY, Dai WC, Fung JYY, Lo CM. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis. Hepatology International. PMID 29450868 DOI: 10.1007/s12072-018-9847-0 |
0.414 |
|
| 2017 |
Ma KW, Cheung TT. When to consider liver transplantation in hepatocellular carcinoma patients? Hepatic Oncology. 4: 15-24. PMID 30191050 DOI: 10.2217/hep-2016-0010 |
0.488 |
|
| 2017 |
Cheung TT. Superior oncological outcome in laparoscopic hepatectomy for hepatocellular carcinoma, hype or hope? Hepatobiliary Surgery and Nutrition. 6: 437-438. PMID 29312985 DOI: 10.21037/hbsn.2017.09.01 |
0.388 |
|
| 2017 |
Ng KKC, Chok KSH, Chan ACY, Cheung TT, Wong TCL, Fung JYY, Yuen J, Poon RTP, Fan ST, Lo CM. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma. The British Journal of Surgery. PMID 29091283 DOI: 10.1002/bjs.10677 |
0.386 |
|
| 2017 |
Yip CW, Lam CY, Poon TCW, Cheung TT, Cheung PFY, Fung SW, Wang XQ, Leung ICY, Ng LWC, Lo CM, Tsao GSW, Cheung ST. Granulin-epithelin precursor interacts with 78-kDa glucose-regulated protein in hepatocellular carcinoma. Bmc Cancer. 17: 409. PMID 28601093 DOI: 10.1186/s12885-017-3399-x |
0.476 |
|
| 2017 |
Kotewall CN, Cheung TT, She WH, Ma KW, Tsang SHY, Dai JWC, Chan ACY, Chok KSH, Lo CM. The role of radiofrequency ablation to liver transection surface in patients with close tumor margin of HCC during hepatectomy-a case matched study. Translational Gastroenterology and Hepatology. 2: 33. PMID 28529987 DOI: 10.21037/tgh.2017.03.19 |
0.4 |
|
| 2017 |
Wu CX, Xu A, Zhang CC, Olson P, Chen L, Lee TK, Cheung TT, Lo CM, Wang XQ. Notch inhibitor PF-03084014 inhibits hepatocellular carcinoma growth and metastasis via suppression of cancer stemness due to reduced activation of Notch1-Stat3. Molecular Cancer Therapeutics. PMID 28522590 DOI: 10.1158/1535-7163.MCT-17-0001 |
0.531 |
|
| 2017 |
Xia W, Lo CM, Poon RYC, Cheung TT, Chan ACY, Chen L, Yang S, Tsao GSW, Wang XQ. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells. Oncotarget. PMID 28415588 DOI: 10.18632/Oncotarget.16402 |
0.35 |
|
| 2017 |
Cui CP, Wong CC, Kai AK, Ho DW, Lau EY, Tsui YM, Chan LK, Cheung TT, Chok KS, Chan AC, Lo RC, Lee JM, Lee TK, Ng IO. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop. Gut. PMID 28258134 DOI: 10.1136/gutjnl-2016-313264 |
0.35 |
|
| 2017 |
Chok KS, Ng KK, Cheung TT, Chan AC, Chan SC, Lo CM. Resection of T4 hepatocellular carcinomas with adjacent structures, is it justified? Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 16: 52-57. PMID 28119259 DOI: 10.1016/S1499-3872(16)60172-8 |
0.409 |
|
| 2017 |
Ma KW, Cheung TT. Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration. Journal of Hepatocellular Carcinoma. 4: 1-9. PMID 28097107 DOI: 10.2147/JHC.S96085 |
0.476 |
|
| 2016 |
Yip VS, Cheung TT, Poon RT, Yau T, Fung J, Dai WC, Chan AC, Chok SH, Chan SC, Lo CM. Does hepatitis B seroconversion affect survival outcome in patients with hepatitis B related hepatocellular carcinoma? Translational Gastroenterology and Hepatology. 1: 51. PMID 28138618 DOI: 10.21037/tgh.2016.05.11 |
0.42 |
|
| 2016 |
She WH, Cheung TT. Bridging and downstaging therapy in patients suffering from hepatocellular carcinoma waiting on the list of liver transplantation. Translational Gastroenterology and Hepatology. 1: 34. PMID 28138601 DOI: 10.21037/tgh.2016.03.04 |
0.394 |
|
| 2016 |
Ho DW, Chan LK, Chiu YT, Xu IM, Poon RT, Cheung TT, Tang CN, Tang VW, Lo IL, Lam PW, Yau DT, Li MX, Wong CM, Ng IO. TSC1/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication. Gut. PMID 27974549 DOI: 10.1136/gutjnl-2016-312734 |
0.395 |
|
| 2016 |
Dai WC, Chok KS, Sin SL, Chan AC, Cheung TT, Wong TC, Lo CM. Impact of intraoperative blood transfusion on long-term outcomes of liver transplantation for hepatocellular carcinoma. Anz Journal of Surgery. PMID 27806436 DOI: 10.1111/ans.13815 |
0.325 |
|
| 2016 |
Cheung AH, Lam CS, Tam HS, Cheung TT, Pang R, Poon RT. Nine-year experience of doxorubicin-eluting beads chemoembolization for hepatocellular carcinoma. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 15: 493-498. PMID 27733318 DOI: 10.1016/S1499-3872(16)60133-9 |
0.485 |
|
| 2016 |
Chai S, Ng KY, Tong M, Lau EY, Lee TK, Wah Chan K, Yuan YF, Cheung TT, Cheung ST, Wang XQ, Wong N, Lo CM, Man K, Guan XY, Ma S. Oct4/miR-1246 signaling axis drives Wnt/β-catenin activation in liver cancer stem cells. Hepatology (Baltimore, Md.). PMID 27639189 DOI: 10.1002/hep.28821 |
0.355 |
|
| 2016 |
Dai WC, Cheung TT. Strategic overview on the best treatment option for intrahepaitc hepatocellular carcinoma recurrence. Expert Review of Anticancer Therapy. PMID 27548586 DOI: 10.1080/14737140.2016.1226136 |
0.338 |
|
| 2016 |
She WH, Chan AC, Cheung TT, Chok KS, Dai WC, Chan SC, Lo CM. Short- and long-term impact of reoperation for complications after major hepatectomy for hepatocellular carcinoma. Surgery. PMID 27498301 DOI: 10.1016/j.surg.2016.06.008 |
0.431 |
|
| 2016 |
Cheung TT, Dai WC, Tsang SH, Chan AC, Chok KS, Chan SC, Lo CM. Pure Laparoscopic Hepatectomy Versus Open Hepatectomy for Hepatocellular Carcinoma in 110 Patients With Liver Cirrhosis: A Propensity Analysis at a Single Center. Annals of Surgery. PMID 27433917 DOI: 10.1097/SLA.0000000000001848 |
0.492 |
|
| 2016 |
She WH, Cheung TT, Jenkins CR, Irwin MG. Clinical applications of high-intensity focused ultrasound. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi / Hong Kong Academy of Medicine. PMID 27380753 DOI: 10.12809/hkmj154755 |
0.36 |
|
| 2016 |
Cheung TT, Wong TC, Chan SC. Technical note on ALPPS for a patient with advanced hepatocellular carcinoma associated with invasion of the inferior vena cava. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. 15: 319-23. PMID 27298110 DOI: 10.1016/S1499-3872(15)60414-3 |
0.369 |
|
| 2016 |
Cheung PF, Yip CW, Ng LW, Lo KW, Chow C, Chan KF, Cheung TT, Cheung ST. Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line. Cancer Cell International. 16: 41. PMID 27279800 DOI: 10.1186/s12935-016-0322-5 |
0.519 |
|
| Show low-probability matches. |